Skip to main content

Advertisement

ADVERTISEMENT

Not Your Typical Angioma

Publisher:Open Science Company, LLC
Jenika S. Karcich, BS, Alexis L. Parcells, MD, and Ramazi O. Datiashvili, MD
Not Your Typical Angioma
Jenika S. Karcich, BS, Alexis L. Parcells, MD, and Ramazi O. Datiashvili, MD

Division of Plastic Surgery, Department of Surgery, Rutgers New Jersey Medical School Newark, NJ

Correspondence: lanteral@njms.rutgers.edu


Keywords: Lymphangioma, thumb angioma, lymphangioma thumb, lymphangioma hand, hand tumor

DESCRIPTION

A 14-month-old female patient presents with a progressively enlarging right thumb mass. Her mother states that the mass developed shortly after birth. The patient had tenderness on palpation of the lesion, and she was noted to have difficulty grasping objects.

QUESTIONS

1. What important history and clinical examination findings differentiate this lesion from similar ones?

2. How is this lesion diagnosed?

3. What are the treatment options?

4. What is the risk of malignant transformation?

DISCUSSION

Lymphangiomas are lymphatic malformations that result from failure of lymphatic channels to connect to their central drainage system, leading to poor lymph flow and fluid accumulation.1,2 Patients clinically present with compressible thin-walled vesicles ranging from clear to deep purple pigmentation.1,3 The lesions often compromise hand function (Fig 1).

Figure 1. Thumb mass

Presentation of these masses is vague and may be easily confused with hemangiomas or venous malformations. Magnetic resonance imaging is useful in demonstrating characteristic lymphatic septa and venous channels that display low signal on T1 and high signal on T2 images4 (Fig 2). Biopsy is diagnostic, with histopathology showing dilated lymph vessels.5 Lymphangiomas are further classified as either microcystic (<2 cm2) or macrocystic (>2 cm2).

Figure 2. Magnetic resonance image of thumb mass.

Treatment of lymphangiomas is challenging, and current treatment regimens are suboptimal. A multidisciplinary approach can be invaluable to coordinating the best care possible for these patients. Noninvasive techniques such as external compression and observation are ineffective in limiting growth.2 Sclerotherapeutic agents including OK-432 and bleomycin have shown to be efficacious in clinical trials for macrocytic lesions (>2 cm), though neither is currently approved for use in the United Stats. Carbon dioxide and Nd:YAG lasers have shown efficacy in decreasing hemorrhage, postoperative pain, and recurrence.6 However, surgical treatment remains the best option for extensive disease in functional or cosmetically sensitive areas. The goals of surgery are to preserve function and improve appearance (Fig 3). Deep and wide excisions are often required to decrease risk of recurrence7 (Fig 4). Regardless of treatment, complete cure is unlikely and recurrence rates are still high. These patients must be closely monitored.

Figure 3. Preoperative marking of thumb mass.
Figure 4. Postoperative excision of thumb mass.

Lymphangiomas present virtually no risk of malignant transformation.7 However, cases of lymphangiosarcoma secondary to chronic lymphedema of an extremity have been documented.

Lymphangioma of the hand is a rare tumor with a vague presentation. Magnetic resonance imaging is an important diagnostic modality. These cases are challenging, and current treatment options to reduce size include sclerosing agents, laser embolization, and surgical excision. Our patient underwent surgical excision with wide margins. Patients must be followed closely for recurrence. Risk of malignant transformation is low.

REFERENCES

1. Godette GA, Rayan GM. Cavernous lymphangioma of the hand. Orthopedics. 1993;16:384-5.

2. Jacobs BJ, Anzarut A, Imbriglia JE. Vascular anomalies of the upper extremity. J Hand Surg. 2010;35:1703-9.

3. Willard KJ, Cappel MA, Kozin SH, Abzug JM. Congenital and infantile skin lesions affecting the hand and upper extremity, part 1: vascular neoplasms and malformations. J Hand Surg. 2013;38:2271-83.

4. Buckmiller LM. Update on hemangiomas and vascular malformations. Curr Opin Otolaryngol Hand Neck Surg. 2004;12:476-87.

5. Annabel M, Shanna B, Gerard L, Soizick PL, Denis H, Allan E. Lack of effect of propanolol in the treatment of lymphangioma in two children. Pediatr Dermatol. 2013;30:383-5.

6. Schachner LA, Hansen RC. Pediatric Dermatology. New York, NY: Churchill Livingstone; 1988.

7. Blair WF, Buckwalter J, Mickelson M, Omer G. Lymphangioma of the forearm and hand. J Hand Surg. 1983;8:399-405.

JOURNAL INFORMATION ARTICLE INFORMATION
Journal ID: ePlasty Volume: 15
ISSN: 1937-5719 E-location ID: ic3
Publisher: Open Science Company, LLC Published: January 12, 2015

Advertisement

Advertisement

Advertisement